Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Red Blood Cell BPGM Deficiency Contributes to Cognitive Impairment Following Ischemic Stroke

Award Number: R21NS140800
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/01/2024
PERIOD OF PERFORMANCE END DATE: 11/30/2026

Group Awards By:

View Award Description

Red Blood Cell BPGM Deficiency Contributes to Cognitive Impairment Following Ischemic Stroke - Project Summary/Abstract Cognitive impairment (CI) affects up to 60% of stroke survivors, significantly impacting morbidity and mortality after stroke. Understanding the mechanisms underlying CI following stroke is crucial for early diagnosis and interventions, potentially slowing or preventing the progression of cognitive decline. Our pilot study identified has identified red blood cells (RBCs) as a novel CI risk factor among stroke patients. The levels of the RBC- specific enzyme, bisphosphoglycerate mutase (BPGM), were notably lower in stroke patients with CI compared to those with normal cognitive function. BPGM plays a pivotal role in the glycolytic pathway within RBCs, influencing the production of 2,3-bisphosphoglycerate (2,3-BPG). 2,3-BPG regulates hemoglobin affinity for oxygen to ensure efficient oxygen delivery to tissues. The observed dysregulation of this process may compromise oxygen supply to the brain, exacerbating hypoxic conditions following stroke. In line with this notion, the hypoxia response in brain vascular cells was activated as a result of BPGM deficiency in RBCs. Additionally, RBC BPGM may influence the vascular production of amyloid beta peptides (Aβ) and the integrity of blood brain barrier (BBB). Therefore, we hypothesize that BPGM deficiency within RBCs may contribute to CI in stroke individuals by inducing neurovascular dysfunction. In this R21 research, we aim to delve into the intricate interplay between RBCs, brain vasculature and post stroke cognitive outcome. We will employ a BPGM knockout (KO) mouse model to investigate how BPGM deficiency in RBCs contributes to CI after stroke, and to explore potential therapeutic strategies, with a specific emphasis on the interaction between RBCs and brain vascular system (Aim 1). Subsequently, we will assess the clinical relevance of RBC BPGM- related metabolism by examining its association with post stroke cognitive outcomes in a larger patient cohort (Aim 2). This research uniquely focuses on the overlooked connection between RBCs and vascular dysfunction in the development of CI after stroke, introducing a novel avenue for investigating vascular contributions to cognitive impairment and dementia (VCID). The findings from the study are anticipated to fill a crucial knowledge gap and lay the foundation for innovative therapeutic interventions and potential clinical applications.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $200,400 )
2026	2026	THE GENERAL HOSPITAL CORPORATION	55 FRUIT ST	BOSTON	MA	02114	SUFFOLK	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	2	12/15/2025	NON-COMPETING CONTINUATION	$200,400
														Subtotal = $200,400

Issue Date FY: 2025 ( Subtotal = $240,350 )
2025	2025	THE GENERAL HOSPITAL CORPORATION	55 FRUIT ST	BOSTON	MA	02114	SUFFOLK	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	001	1	12/16/2024	NEW	-$2,780
2025	2025	THE GENERAL HOSPITAL CORPORATION	55 FRUIT ST	BOSTON	MA	02114	SUFFOLK	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	11/28/2024	NEW	$243,130
														Subtotal = $240,350

Grand Total All Awards = $440,750

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Red Blood Cell BPGM Deficiency Contributes to Cognitive Impairment Following Ischemic Stroke

Award Number: R21NS140800

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/01/2024

PERIOD OF PERFORMANCE END DATE: 11/30/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer